IL6 and prostate carcinoma: Previously [1], we have proposed our hypothesis that glucosamine could inhibit the N-glycosylation of IL-6 receptor in human prostate carcinoma DU145 cells, thereby reducing the activity of the IL-6/JAK/STAT3 signaling pathway.